Brief: Ambu Cuts FY Outlook, Now Sees Adj. EBIT Margin at 5-6%
Aug 31 (Reuters) - Ambu Narrows FY 2022/23 guidance * Outlook FY organic growth 6-8%. * Outlook FY adjusted EBIT margin 5-6%
Recent news on Ambu A/S
See all newsBrief: Ambu Says Two Bronchoscopes Get FDA Clearance, CE Mark For Use In Pediatric Airway Procedures
Brief: Ambu Obtains Regulatory Clearances For Expanded GI Indication
UBS turns cautious on Ambu's targets, cuts to 'neutral'
Brief: Ambu Acquires TIMS Medical To Advance Endointelligence
Brief: Ambu Reports Q3 EBIT DKK 221 Mln